Androgen Receptor Signaling Mediated By a Novel Fusion Mutant Discovered in Men With Castration-Resistant Prostate Cancer

被引:0
|
作者
Lu, Changxue [1 ]
Chen, Yan [1 ]
Nakazawa, Mary [1 ]
Luo, Jun [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1844
引用
收藏
页码:460A / 461A
页数:2
相关论文
共 50 条
  • [21] Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (01) : 76 - 78
  • [22] Minnelide reduces castration-resistant and enzalutamide-resistant prostate cancer via downregulation of androgen receptor-mediated signaling
    Isharwal, Sumit
    Modi, Shrey
    Barlass, Usman
    Dudeja, Vikas
    Saluja, Ashok
    Banerjee, Sulagna
    Konety, Badrinath
    CANCER RESEARCH, 2015, 75
  • [23] Synthesis and evaluation of a novel class of androgen receptor signaling axis inhibitors targeting castration-resistant prostate cancer
    Ralalage, D. Elshan N. G.
    An, Jiabin
    Rettig, Matthew
    Jung, Michael
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [24] Novel Therapeutic Strategies for Castration Resistant Prostate Cancer: Inhibition of Persistent Androgen Production and Androgen Receptor Mediated Signaling
    Molina, Arturo
    Belldegrun, Arie
    JOURNAL OF UROLOGY, 2011, 185 (03): : 787 - 794
  • [25] Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer
    Nakayama, Hiroshi
    Sekine, Yoshitaka
    Oka, Daisuke
    Miyazawa, Yoshiyuki
    Arai, Seiji
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Suzuki, Kazuhiro
    PROSTATE, 2022, 82 (03): : 314 - 322
  • [26] Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer
    Yu, Jiang
    Zhang, Lanxi
    Yan, Guoyi
    Zhou, Peiting
    Cao, Chaoguo
    Zhou, Fei
    Li, Xinghai
    Chen, Yuanwei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 171 : 265 - 281
  • [27] Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer
    Singh, Krishna B.
    Ji, Xinhua
    Singh, Shivendra V.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (10) : 2079 - 2090
  • [28] COMBINATION THERAPY WITH NOVEL ANDROGEN RECEPTOR ANTAGONISTS AND STATIN FOR CASTRATION-RESISTANT PROSTATE CANCER
    Nakayama, Hiroshi
    Sekine, Yoshitaka
    Oka, Daisuke
    Aoki, Masanori
    Ohtsu, Akira
    Miyazawa, Yoshiyuki
    Syuto, Takahiro
    Arai, Seiji
    Nomura, Masashi
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Suzuki, Kazuhiro
    JOURNAL OF UROLOGY, 2020, 203 : E1207 - E1208
  • [29] Developing small molecule inhibitors that target androgen receptor signaling in castration-resistant prostate cancer
    Chandrasekaran, Balaji
    Tyagi, Ashish
    Kolluru, Venkatesh
    Vadhanam, Aakash M.
    von Baby, Becca
    Gorle, Suresh
    Sirimulla, Suman
    Ramisetti, Srinivasa R.
    Sharma, Arun K.
    Ankem, Murali K.
    Damodaran, Chendil
    CANCER RESEARCH, 2019, 79 (13)
  • [30] Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
    Zadra, Giorgia
    Ribeiro, Caroline F.
    Chetta, Paolo
    Ho, Yeung
    Cacciatore, Stefano
    Gao, Xueliang
    Syamala, Sudeepa
    Bango, Clyde
    Photopoulos, Cornelia
    Huang, Ying
    Tyekucheva, Svitlana
    Bastos, Debora C.
    Tchaicha, Jeremy
    Lawney, Brian
    Uo, Takuma
    D'Anello, Laura
    Csibi, Alfredo
    Kalekar, Radha
    Larimer, Benjamin
    Ellis, Leigh
    Butler, Lisa M.
    Morrissey, Colm
    McGovern, Karen
    Palombella, Vito J.
    Kutok, Jeffery L.
    Mahmood, Umar
    Bosari, Silvano
    Adams, Julian
    Peluso, Stephane
    Dehm, Scott M.
    Plymate, Stephen R.
    Loda, Massimo
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (02) : 631 - 640